Altered Proteome Biology of Cardiac Mitochondria Under Stress Conditions

Abstract

Myocardial ischemia-reperfusion induces mitochondrial dysfunction and, depending upon the degree of injury, may lead to cardiac cell death. However, our ability to understand mitochondrial dysfunction has been hindered by an absence of molecular markers defining the various degrees of injury. To address this paucity of knowledge, we sought to characterize the impact of ischemic damage on mitochondrial proteome biology. We hypothesized that ischemic injury induces differential alterations in various mitochondrial sub-compartments, that these proteomic changes are specific to the severity of injury, and that they are important to subsequent cellular adaptations to myocardial ischemic injury. Accordingly, an in vitro model of cardiac mitochondria injury in mice was established to examine two stress conditions: reversible injury (induced by mild calcium overload) and irreversible injury (induced by hypotonic stimuli). Both forms of injury had a drastic impact on the proteome biology of cardiac mitochondria. Altered mitochondrial function was concomitant with significant protein loss/shedding from the injured organelles. In the setting of mild calcium overload, mitochondria retained functionality despite the release of numerous proteins, and the majority of mitochondria remained intact. In contrast, hypotonic stimuli caused severe damage to mitochondrial structure and function, induced increased oxidative modification of mitochondrial proteins, and brought about detrimental changes to the sub proteomes of the inner mitochondrial membrane and matrix. Using an established in vivo murine model of regional myocardial ischemic injury, we validated key observations made by the in vitro model. This preclinical investigation provides function and sub-organelle location information on a repertoire of cardiac mitochondrial proteins sensitive to ischemia reperfusion stress and highlights protein clusters potentially involved in mitochondrial dysfunction in the setting of ischemic injury.

Quantitative Proteomics Discloses MET Expression in Mitochondria as a Direct Target of MET Kinase Inhibitor in Cancer Cells

“…6A). Equal loading of proteins for whole-cell lysate and mitochondria fraction was confirmed by Ponceau S staining (45).…”

Hyperthyroidism causes cardiac dysfunction by mitochondrial impairment and energy depletion

“…Mitochondria produces a major part of reactive oxygen species (ROS) in cell as a byproduct of the electron transport chain, which is detoxified by the cellular antioxidant system under physiological conditions (Gustafsson & Gottlieb 2008, Zhang et al 2008. Excess T 3 induces a hypermetabolic state in the heart and also increases cellular respiration leading to increased ROS production, which is not completely neutralized by the cellular antioxidants, and there is gradual and progressive accumulation of ROS in cardiomyocytes (Ghosh et al 2007, Abel & Doenst 2011.…”

PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death

“…Mitochondria and submitochondrial particles were isolated from the livers of PON3 þ / þ or PON3 À/À mice on C57BL/6J background as described previously, [34][35][36] and their protein extracts (50 mg per sample) were resolved by 4-15% SDS-PAGE, transferred onto nitrocellulose membranes and blocked in TBS containing 3% milk protein for 1 h. Mouse or human PON3 antibody were used at 1:500 (R&D Systems), Histone 1 antibody was used at 1:250 (Santa Cruz Biotechnology), Calnexin antibody was used at 1:1000 (Assay Designs, Ann Arbor, MI, USA), antivoltage-dependent anion channel 1 was used at 1:500 (Cell Signaling Technology), human cytochrome oxidase antibody was used at 1:500 and mouse cytochrome oxidase antibody was used at 1:250 dilution (Cell Signaling Technology). Primary antibodies were diluted in TBS containing 5% milk protein at 41C overnight.…”